Form S-3 Stoke Therapeutics, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Stoke Therapeutics Inc. (STOK) Files $400M Mixed Shelf
July 9, 2025 4:04 PM EDTStoke Therapeutics Inc. (NASDAQ: STOK) has filed $400,000,000 mixed shelf of:
Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units
... More


